Hirschberg A L
Department of Obstetrics and Gynecology, Karolinska Hospital, Stockholm, Sweden.
Ann Med. 1998 Feb;30(1):7-20. doi: 10.3109/07853899808999380.
Several clinical disorders are strongly influenced by hormones involved in appetite and weight regulation. Obesity and eating disorders are of major importance, because they are associated with severe morbidity and considered to be among the greatest health problems in the Western world today. This review describes recent findings in hormonal regulation of food intake by substances acting both centrally, such as corticotropin-releasing factor, neuropeptide Y and leptin, and peripherally, such as cholecystokinin and somatostatin. Sex hormones and glucocorticoids play an important role in long-term regulation of metabolism. The role of these hormones in appetite and weight changes during life as well as during pregnancy and lactation is discussed. Furthermore, the development of obesity and eating disorders is influenced, in particular, by steroid hormones. Treatment with sex hormones, as in hormone replacement therapy, affects appetite and weight and may have beneficial effects in preventing android obesity. Currently, there is great effort in developing endogenous neurohumoral substances into effective drugs for the treatment of obesity and eating disorders. Leptin and neuropeptide Y analogues are of interest as potential antiobesity agents.
几种临床疾病受到参与食欲和体重调节的激素的强烈影响。肥胖症和饮食失调至关重要,因为它们与严重的发病率相关,并且被认为是当今西方世界最严重的健康问题之一。本综述描述了近期关于通过中枢作用的物质(如促肾上腺皮质激素释放因子、神经肽Y和瘦素)以及外周作用的物质(如胆囊收缩素和生长抑素)对食物摄入进行激素调节的研究结果。性激素和糖皮质激素在新陈代谢的长期调节中起重要作用。讨论了这些激素在生命过程中以及妊娠和哺乳期对食欲和体重变化的作用。此外,肥胖症和饮食失调的发展尤其受到类固醇激素的影响。如在激素替代疗法中使用性激素进行治疗,会影响食欲和体重,并且可能在预防腹型肥胖方面具有有益作用。目前,人们正在大力努力将内源性神经体液物质开发成治疗肥胖症和饮食失调的有效药物。瘦素和神经肽Y类似物作为潜在的抗肥胖药物受到关注。